Womack C, Elston C W
Placenta. 1985 Mar-Apr;6(2):93-105. doi: 10.1016/s0143-4004(85)80060-6.
The results of a 12-year retrospective study on the epidemiology of hydatidiform mole (HM) in Nottingham are presented. We have reviewed the histology of our cases of HM, tried to minimize selection bias, and have used the most reliable data available. Using data from two different sources we have calculated the frequency of HM as 1 in 1400 deliveries. The frequency of HM in this study is one quarter of that reported in an excellent study from Japan. We suggest that, with accurate epidemiological studies, the difference in frequency of HM between 'high risk' and 'low risk' areas is less than previously accepted. The present study also shows a lower incidence of persistent trophoblastic disease than previously generally accepted. We confirm that partial HM is a distinct clinicopathological entity and that two forms are distinguishable histologically. The malignant potential of partial HM is uncertain, and we suggest that the clinical management of partial HM should be no different from that of complete HM until further studies dictate otherwise.
本文呈现了一项针对诺丁汉地区葡萄胎(HM)流行病学的12年回顾性研究结果。我们回顾了葡萄胎病例的组织学情况,尽量减少选择偏倚,并使用了可得的最可靠数据。利用来自两个不同来源的数据,我们计算出葡萄胎的发生率为每1400例分娩中有1例。本研究中葡萄胎的发生率是日本一项出色研究报告发生率的四分之一。我们认为,通过准确的流行病学研究,“高风险”和“低风险”地区之间葡萄胎发生率的差异比之前公认的要小。本研究还显示,持续性滋养细胞疾病的发生率低于之前普遍公认的水平。我们证实部分性葡萄胎是一种独特的临床病理实体,并且在组织学上可区分出两种类型。部分性葡萄胎的恶性潜能尚不确定,我们建议在有进一步研究表明并非如此之前,部分性葡萄胎的临床管理应与完全性葡萄胎无异。